Heart Defects, Congenital - 26 Studies Found
| Terminated |
: Effects of Perioperative Nesiritide or Milrinone Infusion on Recovery From Fontan Surgery : Heart Defects, Congenital : 2007-10-10 :
|
| Completed |
: Physical Activity in Fontan Patients : Heart Defects, Congenital : 2006-08-10 :
|
| Terminated |
: Using Tissue Doppler/Synchronization to Determine Heart Function in Children With Congenital Heart Disease : Congenital Heart Defects : 2005-09-13 |
| Completed |
: Pre-operative Cerebral Oxygenation in Neonates With Congenital Heart Disease : Heart Defects, Congenital : 2012-08-31 : Other: measuring cerebral oxygenation |
| Not yet recruiting |
: Xeltis Bioabsorbable Pulmonary Valved Conduit Early Feasibility Study : Heart Defect, Congenital : 2017-01-10 : Device: Xeltis Bioabsorbable Pulmonary Valved Conduit Surgical implantation of Xeltis Bioabsorbable Pulm |
| Withdrawn |
: Tranexamic Acid Effect on Platelet Aggregation Following Infant Cardiopulmonary Bypass : Heart Defect, Congenital : 2014-04-23 :
|
| Enrolling by invitation |
: CTICU Pacifier Activated Music Player and Mother's Voice : Heart Defects, Congenital : 2017-01-23 : Behavioral: Pacifier activated music player Therefore the immediate goal of the current proposal is to d |
| Completed |
: The Fontan Education Study: A Randomized Control Trial : Heart Defects, Congenital : 2016-07-11 : Other: Fontan Education Videos The intervention will consi |
| Completed |
: Right Lateral Positioning of Postoperative Pediatric Cardiac Surgery : Heart Defects, Congenital : 2015-11-28 :
|
| Terminated |
: Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery: Proposal for Pilot Investigation : Heart Defects, Congenital : 2015-05-14 : Drug: Dexrazoxane Dose escalation every 4 subjects from 200mg/m2/dose; 300mg/m2/dose to 400mg/m2/dose |